BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30551436)

  • 1. Effect of oral magnesium sulfate administration on blood glucose hemostasis via inhibition of gluconeogenesis and FOXO1 gene expression in liver and muscle in diabetic rats.
    Barooti A; Kamran M; Kharazmi F; Eftakhar E; Malekzadeh K; Talebi A; Soltani N
    Biomed Pharmacother; 2019 Jan; 109():1819-1825. PubMed ID: 30551436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.
    Sohrabipour S; Sharifi MR; Sharifi M; Talebi A; Soltani N
    Fundam Clin Pharmacol; 2018 Dec; 32(6):603-616. PubMed ID: 29869808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Long-term Administration of Oral Magnesium Sulfate and Insulin to Reduce Streptozotocin-Induced Hyperglycemia in Rats: the Role of Akt2 and IRS1 Gene Expressions.
    Kamran M; Kharazmi F; Malekzadeh K; Talebi A; Khosravi F; Soltani N
    Biol Trace Elem Res; 2019 Aug; 190(2):396-404. PubMed ID: 30519800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
    Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
    Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
    Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
    Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PPAR-γ and NFKB genes expression in muscle to improve hyperglycemia in STZ-induced diabetic rat following magnesium sulfate administration.
    Khosravi F; Kharazmi F; Kamran M; Malekzadeh K; Talebi A; Soltani N
    Int J Physiol Pathophysiol Pharmacol; 2018; 10(3):124-131. PubMed ID: 30042813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of GLUT4 expression by oral administration of Mg(2+) to control sugar levels in STZ-induced diabetic rats.
    Solaimani H; Soltani N; MaleKzadeh K; Sohrabipour S; Zhang N; Nasri S; Wang Q
    Can J Physiol Pharmacol; 2014 Jun; 92(6):438-44. PubMed ID: 24821133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral magnesium sulfate administration on lectin-like oxidized low-density lipoprotein receptor-1 gene expression to prevent atherosclerosis in diabetic rat vessels.
    Fazlali M; Kharazmi F; Kamran M; Malekzadeh K; Talebi A; Khosravi F; Soltani N
    J Diabetes Investig; 2019 May; 10(3):650-658. PubMed ID: 30328289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats.
    Huang W; Yu J; Jia X; Xiong L; Li N; Wen X
    Am J Chin Med; 2012; 40(4):721-33. PubMed ID: 22809027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
    Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
    Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
    Chan P; Wong KL; Liu IM; Tzeng TF; Yang TL; Cheng JT
    J Hypertens; 2003 Apr; 21(4):761-9. PubMed ID: 12658023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
    Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
    Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
    Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium sulfate improves insulin resistance in high fat diet induced diabetic parents and their offspring.
    Rezazadeh H; Sharifi MR; Sharifi M; Soltani N
    Eur J Pharmacol; 2021 Oct; 909():174418. PubMed ID: 34411605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats.
    Becker DJ; Reul B; Ozcelikay AT; Buchet JP; Henquin JC; Brichard SM
    Diabetologia; 1996 Jan; 39(1):3-11. PubMed ID: 8720597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA administration improves liver function and insulin resistance in offspring of type 2 diabetic rats.
    Hosseini Dastgerdi A; Sharifi M; Soltani N
    Sci Rep; 2021 Nov; 11(1):23155. PubMed ID: 34848753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
    Yarushkin AA; Kachaylo EM; Pustylnyak VO
    Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.